Message from the BOPA Research Committee

We are delighted to announce that we have received a record-breaking number of abstracts for the 2022 Symposium in Liverpool.  A crack team of markers are now in the process of reviewing all the abstracts and we are aiming to notify all lead authors by 2nd September if their work has been accepted.   The original abstract deadline has now closed but we will still be accepting “Late-Breaking Abstracts” (eligible for poster presentation but will not be considered for oral presentation) until Monday 8th August.  So if you have recently completed a piece of work that you would love to share, its not too late to put together and submit an abstract!

 

Submit here

Latest News

By BOPA Digital Subcommittee on 16th February 2026

BOPA Social Media & Communication Preferences Survey

Dear BOPA member, The BOPA digital subcommittee is conducting a short survey to better understand how pharmacy healthcare professionals working in oncology use social media and how they prefer to…

Read article
By BOPA E&T Subcommittee on 16th February 2026

Cancer Advanced and Consultant Pharmacist credentialing support series – First session

First session: Wednesday 25th February 3:30pm   BOPA are continuing their supportive webinar series for pharmacists who are credentialing as advanced and consultant pharmacists with the RPS.   Format: There…

Read article
By BOPA on 16th February 2026

Invitation to apply for Principles of Geriatric Oncology Module at Royal Marsden School

Dear BOPA Member, We are pleased to invite applications for the postgraduate module Principles of Geriatric Oncology, delivered fully online by The Royal Marsden School, commencing on 13 April 2026.…

Read article
By Caoimhe Keenan on 16th February 2026

Workshop Exploring Support for Patients with Advanced Cancer in Primary Care

On behalf of CASPC, We would like to invite you to an interactive workshop at the Christe Hospital,  Manchester, on 23rd April 5.30-8pm (please see attached flyer), to explore support…

Read article